Nan Fung Group Holdings as of March 31, 2022
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 45 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Illumina (ILMN) | 21.5 | $45M | 130k | 349.40 | |
| Harmony Biosciences Hldgs In (HRMY) | 17.7 | $37M | 769k | 48.65 | |
| Karuna Therapeutics Ord | 14.1 | $30M | 235k | 126.79 | |
| Eargo | 7.2 | $15M | 2.9M | 5.29 | |
| Somalogic Class A Com | 6.5 | $14M | 1.7M | 8.02 | |
| Exscientia Ads (EXAI) | 5.3 | $11M | 770k | 14.40 | |
| Seagen | 3.2 | $6.8M | 47k | 144.05 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 3.2 | $6.7M | 494k | 13.50 | |
| Xenon Pharmaceuticals (XENE) | 2.9 | $6.0M | 198k | 30.57 | |
| Vir Biotechnology (VIR) | 2.6 | $5.4M | 211k | 25.72 | |
| Bolt Biotherapeutics (BOLT) | 1.5 | $3.2M | 1.2M | 2.74 | |
| Beam Therapeutics (BEAM) | 1.5 | $3.1M | 55k | 57.30 | |
| Incyte Corporation (INCY) | 1.3 | $2.7M | 34k | 79.41 | |
| Beigene Sponsored Adr (BGNE) | 1.1 | $2.3M | 12k | 188.57 | |
| Otonomy | 1.0 | $2.0M | 851k | 2.40 | |
| Sierra Oncology Com New | 0.8 | $1.7M | 53k | 32.05 | |
| Entrada Therapeutics (TRDA) | 0.8 | $1.6M | 174k | 9.39 | |
| Galera Therapeutics (GRTX) | 0.7 | $1.5M | 613k | 2.38 | |
| Exelixis (EXEL) | 0.7 | $1.5M | 64k | 22.66 | |
| Pacific Biosciences of California (PACB) | 0.6 | $1.3M | 145k | 9.10 | |
| Replimune Group (REPL) | 0.6 | $1.3M | 75k | 16.98 | |
| Invitae (NVTAQ) | 0.6 | $1.2M | 156k | 7.97 | |
| EXACT Sciences Corporation (EXAS) | 0.6 | $1.2M | 18k | 69.92 | |
| Kalvista Pharmaceuticals (KALV) | 0.6 | $1.2M | 79k | 14.74 | |
| Chemocentryx | 0.4 | $898k | 36k | 25.06 | |
| ACADIA Pharmaceuticals (ACAD) | 0.3 | $726k | 30k | 24.21 | |
| Alx Oncology Hldgs (ALXO) | 0.3 | $709k | 42k | 16.90 | |
| 2seventy Bio Common Stock (TSVT) | 0.3 | $687k | 40k | 17.06 | |
| Dbv Technologies S A Sponsored Adr (DBVT) | 0.3 | $590k | 371k | 1.59 | |
| Satsuma Pharmaceuticals Ord | 0.3 | $543k | 143k | 3.80 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.2 | $489k | 4.2k | 117.32 | |
| BioMarin Pharmaceutical (BMRN) | 0.2 | $471k | 6.1k | 77.02 | |
| Affimed Therapeutics B V | 0.2 | $355k | 81k | 4.37 | |
| Argenx Se Sponsored Adr (ARGX) | 0.2 | $350k | 1.1k | 315.32 | |
| Rubius Therapeutics | 0.1 | $313k | 57k | 5.51 | |
| Sarepta Therapeutics (SRPT) | 0.1 | $306k | 3.9k | 78.12 | |
| Reata Pharmaceuticals Cl A | 0.1 | $271k | 8.3k | 32.79 | |
| Fibrogen (FGEN) | 0.1 | $177k | 15k | 12.00 | |
| Synlogic | 0.1 | $165k | 69k | 2.40 | |
| Kodiak Sciences (KOD) | 0.1 | $151k | 20k | 7.70 | |
| Abcellera Biologics (ABCL) | 0.1 | $122k | 13k | 9.74 | |
| Day One Biopharmaceuticals I (DAWN) | 0.1 | $114k | 11k | 9.96 | |
| Dyne Therapeutics (DYN) | 0.1 | $112k | 12k | 9.63 | |
| Cerus Corporation (CERS) | 0.0 | $78k | 14k | 5.50 | |
| Tcr2 Therapeutics Inc cs | 0.0 | $53k | 19k | 2.74 |
